Tempest Therapeutics Inc. Soared
Wed, Apr 27, 2022 at 05:30 PM
Tempest Therapeutics Inc. (TPST:NASDAQ) soared at $3.07, representing a gain of 30.1%. On Tue, Apr 26, 2022, TPST:NASDAQ hit a New 2-Week Low of $2.36. The stock appeared on our News Catalysts scanner on Wed, Apr 27, 2022 at 10:09 AM in the 'PRIVATE PLACEMENT' category. From Wed, Apr 13, 2022, the stock recorded 25.00% Up Days and 22.22% Green Days
About Tempest Therapeutics Inc. (TPST:NASDAQ)
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific...
Top 10 Gainers:
- Acutus Medical Inc. (AFIB:NASDAQ), 36%
- Locafy Limited (LCFY:NASDAQ), 34.19%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 30.08%
- Studio City International Holdings Limited (MSC:NYSE), 29.73%
- Canterbury Park Holding Corporation (CPHC:NASDAQ), 22.24%
- Bon Natural Life Limited (BON:NASDAQ), 18.54%
- Elevation Oncology Inc. (ELEV:NASDAQ), 17.84%
- PAVmed Inc. (PAVM:NASDAQ), 16.51%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 16.36%
- Chindata Group Holdings Limited (CD:NASDAQ), 15.34%